Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel Peter Petrylak, Ronald de Wit, Kim N. Chi et al. · The Lancet · 2017

Cited by 171 works. doi:10.1016/s0140-6736(17)32365-6 Open-access PDF

Authors

References